1Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
二级参考文献28
1Moses JW, Leon MB, Poprna JJ, et al. Sirolimus-eluting s-tents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003,349:1315-1323. 被引量：1
2Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-Ⅳ trial. Circulation. 2004;109:1942 - 1947. 被引量：1
3Moses JW. CYPHER trials. Presented at: American College of Cardiology Annual Scientific Session 2006 Rapid News Summaries; March 11-14, 2006; Atlanta, Ga. http://www.cardiosource.com /rapid newssu mmaries/index.asp?EID=22 &DoW=Mon&SumID=165. Accessed July 1, 2006. 被引量：1
4Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report fiom the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113:e85-e151. 被引量：1
5Leon MB, Bairn DS, Popma J J, et al; Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenUng. N Engl J Med. 1998;339: 1665-1671. 被引量：1
6Cutlip DE, Balm DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001, 103:1967-1971. 被引量：1
7Berger PB, Mahaffey KW, Meier S J, et al. Safety and efficacy of only 2 weeks of ticlopicline therapy in patients at increased dsk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial. Am Heart J. 2002;143:841-846. 被引量：1
8Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130. 被引量：1
9Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug- eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-2809. 被引量：1
10Regar E, Lemos PA, Saia F, et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol. 2004;93:1271- 1275. 被引量：1
5Chen ZM,Jiang LX,Chen YP,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infaetion: randomized placebo-controlled trial [J]. Lancet, 2005, 366 (9497) : 1607-1620. 被引量：1
6Bottorff MB, Nuetescu EA, Spinier S. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvements initiative[J]. Pharmacotherapy, 2007,27 (8) : 1145-1162. 被引量：1
7Lanas A, Fuentes J, Benito R, et al. Hetieobacter pylori inereases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin[J]. Aliment Pharmaeol Ther, 2002,16 (4) :779-786. 被引量：1
8Bhatt DL,Seheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Fask Force on Clinical Expert Consensus Documents [J]. Circulation, 2008,118(18) : 1894-1909. 被引量：1
9Sibbing D, Morath T,Stegherr J,et al. Impact of proton pump inhibitors on the antiplatelet effects of elopidogrel[J]. Thromb Haemest,2009,101(4) :714-719. 被引量：1
